Search Results

There are 2999 results for: content related to: Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer

  1. You have free access to this content
    In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole

    British Journal of Clinical Pharmacology

    Volume 70, Issue 6, December 2010, Pages: 854–869, Landry K. Kamdem, Yong Liu, Vered Stearns, Susan A. Kadlubar, Jacqueline Ramirez, Stacie Jeter, Karineh Shahverdi, Bryan A. Ward, Evan Ogburn, Mark J. Ratain, David A. Flockhart and Zeruesenay Desta

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1365-2125.2010.03791.x

  2. Fulvestrant for hormone-sensitive metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Clara I Lee, Annabel Goodwin and Nicholas Wilcken

    Published Online : 3 JAN 2017, DOI: 10.1002/14651858.CD011093.pub2

  3. You have free access to this content
    Patterns of change in cognitive function with anastrozole therapy

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2627–2636, Catherine M. Bender, John D. Merriman, Amanda L. Gentry, Gretchen M. Ahrendt, Sarah L. Berga, Adam M. Brufsky, Frances E. Casillo, Meredith M. Dailey, Kirk I. Erickson, Frances M. Kratofil, Priscilla F. McAuliffe, Margaret Q. Rosenzweig, Christopher M. Ryan and Susan M. Sereika

    Version of Record online : 23 APR 2015, DOI: 10.1002/cncr.29393

  4. You have free access to this content
    Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

    Cancer

    Volume 92, Issue 9, 1 November 2001, Pages: 2247–2258, Jacques Bonneterre, Aman Buzdar, Jean-Marc A. Nabholtz, John F. R. Robertson, Bert Thürlimann, Mikael von Euler, Tarek Sahmoud, Alan Webster, Mark Steinberg and Arimidex Writing Committee on behalf of the Investigators Committee Members

    Version of Record online : 23 OCT 2001, DOI: 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y

  5. You have free access to this content
    A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma

    Cancer

    Volume 79, Issue 4, 15 February 1997, Pages: 730–739, Aman U. Buzdar, Stephen E. Jones, Charles L. Vogel, Janet Wolter, Paul Plourde, Alan Webster and for the Arimidex Study Group

    Version of Record online : 27 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0

  6. You have free access to this content
    Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor

    International Journal of Cancer

    Volume 133, Issue 7, 1 October 2013, Pages: 1589–1602, Paul Vilquin, Marie Villedieu, Evelyne Grisard, Sabrina Ben Larbi, Sandra E. Ghayad, Pierre-Etienne Heudel, Thomas Bachelot, Laura Corbo, Isabelle Treilleux, Julie A. Vendrell and Pascale A. Cohen

    Version of Record online : 2 MAY 2013, DOI: 10.1002/ijc.28182

  7. You have free access to this content
    Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 704–713, Hiroji Iwata, Norikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, Seigo Nakamura, Yasuhiro Yanagita, Reiki Nishimura, Hirotaka Iwase, Shunji Kamigaki, Hiroyuki Takei, Hitoshi Tsuda, Nobuya Hayashi and Shinzaburo Noguchi

    Version of Record online : 12 SEP 2012, DOI: 10.1002/cncr.27818

  8. You have free access to this content
    Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor–positive breast cancer

    Cancer

    Volume 101, Issue 6, 15 September 2004, Pages: 1311–1322, Bruce E. Hillner

    Version of Record online : 6 AUG 2004, DOI: 10.1002/cncr.20492

  9. You have free access to this content
    Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226

    British Journal of Clinical Pharmacology

    Volume 81, Issue 6, June 2016, Pages: 1134–1141, Daniel L. Hertz, William E. Barlow, Kelley M. Kidwell, Kathy S. Albain, Ted A. Vandenberg, Shaker R. Dakhil, Nagendra R. Tirumali, Robert B. Livingston, Julie Gralow, Daniel F. Hayes, Gabriel N. Hortobagyi, Rita S. Mehta and James M. Rae

    Version of Record online : 8 APR 2016, DOI: 10.1111/bcp.12904

  10. You have full text access to this Open Access content
    Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen

    Cancer Science

    Volume 103, Issue 3, March 2012, Pages: 491–496, Yasuhiro Fujiwara, Yuichi Takatsuka, Shigeru Imoto, Hideo Inaji, Tadashi Ikeda, Futoshi Akiyama, Motoshi Tamura, Kazuya Miyoshi, Hiroji Iwata, Shoshu Mitsuyama and Shinzaburo Noguchi

    Version of Record online : 13 JAN 2012, DOI: 10.1111/j.1349-7006.2011.02171.x

  11. Hydrophilic interaction chromatography–electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 26, Issue 2, February 2012, Pages: 261–266, Hye Young Ji, Ji-Hong Sohn and Hye Suk Lee

    Version of Record online : 8 JUN 2011, DOI: 10.1002/bmc.1658

  12. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Intervention Review

    The Cochrane Library

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD003370.pub3

  13. You have free access to this content
    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 241–247, Antonio Llombart-Cussac, Amparo Ruiz, Antonio Antón, Agustí Barnadas, Silvia Antolín, José E. Alés-Martínez, Isabel Álvarez, Raquel Andrés, José A. García Saenz, Juan Lao, Eva Carrasco, Carmen Cámara, Isabel Casas and Miguel Martín

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26299

  14. You have free access to this content
    Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women

    Cancer

    Volume 98, Issue 2, 15 July 2003, Pages: 229–238, John F. R. Robertson, C. Kent Osborne, Anthony Howell, Stephen E. Jones, Louis Mauriac, Matthew Ellis, Ulrich R. Kleeberg, Steven E. Come, Ignace Vergote, Stan Gertler, Aman Buzdar, Alan Webster and Charles Morris

    Version of Record online : 2 JUN 2003, DOI: 10.1002/cncr.11468

  15. An ultraperformance liquid chromatography–tandem mass spectrometry method for determination of anastrozole in human plasma and its application to a pharmacokinetic study

    Biomedical Chromatography

    Volume 25, Issue 4, April 2011, Pages: 511–516, Jia Yu, Jifen He, Yi Zhang, Feng Qin, Zhili Xiong and Famei Li

    Version of Record online : 13 JUL 2010, DOI: 10.1002/bmc.1476

  16. You have free access to this content
    The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2001, Pages: 429–435, R. A. Yates, J. Wong, M. Seiberling, M. Merz, W. März and M. Nauck

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1365-2125.2001.01358.x

  17. You have free access to this content
    Investigation of the effect of active efflux at the blood–brain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3309–3319, Mari Miyajima, Hiroyuki Kusuhara, Kayo Takahashi, Tadayuki Takashima, Takamitsu Hosoya, Yasuyoshi Watanabe and Yuichi Sugiyama

    Version of Record online : 27 MAY 2013, DOI: 10.1002/jps.23600

  18. You have free access to this content
    An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

    Cancer

    Volume 95, Issue 9, 1 November 2002, Pages: 2006–2016, Aman U. Buzdar, John F. R. Robertson, Wolfgang Eiermann and Jean-Marc Nabholtz

    Version of Record online : 25 OCT 2002, DOI: 10.1002/cncr.10908

  19. You have free access to this content
    Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma

    Cancer

    Volume 83, Issue 6, 15 September 1998, Pages: 1142–1152, Aman U. Buzdar, Walter Jonat, Anthony Howell, Stephen E. Jones, Carl P. Blomqvist, Charles L. Vogel, Wolfgang Eiermann, Janet M. Wolter, Mark Steinberg, Alan Webster and David Lee

    Version of Record online : 9 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.0.CO;2-5

  20. Pre-treatment with anastrozole may be the optimal treatment sequence with radiotherapy for breast cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 4, Issue 1, March 2008, Pages: 27–33, Peter H GRAHAM, Zhi-Ming FANG and Raymond A CLARKE

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1743-7563.2008.00144.x